Bloomberg Business

Catalent Reaches Deal With Elliott, Adds New Seats to Board

Catalent Inc., the drug-product manufacturer dogged by issues at its facilities, will add four new members to its board and undertake a strategic review as part of a settlement with activist investor Elliott Investment Management.

EU to Stick With Climate Ambitions Despite Mounting Backlash

The European Commission will stand firm on its climate objectives while aiming to ensure that companies and citizens continue to support the transition to net-zero emissions, pledged the new head of the bloc’s landmark green deal.

Close Bitnami banner
Bitnami